Nuvectis Pharma, Inc.

NasdaqCM:NVCT Stock Report

Market Cap: US$124.2m

Nuvectis Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:NVCT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Mar 24BuyUS$51,450Ron BentsurIndividual5,000US$10.29
10 Oct 23BuyUS$7,091Ron BentsurIndividual640US$11.08
09 Oct 23BuyUS$12,105Ron BentsurIndividual1,080US$11.27
05 Oct 23BuyUS$35,455Ron BentsurIndividual3,220US$11.09
16 Aug 23BuyUS$5,112Ron BentsurIndividual350US$15.15
11 Aug 23BuyUS$4,418Ron BentsurIndividual300US$14.83
31 Jul 23BuyUS$11,937Charles Mosseri-MarlioIndividual860US$13.88
28 Jul 23BuyUS$35,943Charles Mosseri-MarlioIndividual2,584US$13.91
27 Jul 23BuyUS$21,753Charles Mosseri-MarlioIndividual1,556US$13.98
26 Jul 23BuyUS$139,700Charles Mosseri-MarlioIndividual10,000US$13.97
21 Jul 23BuyUS$119,224Charles Mosseri-MarlioIndividual8,238US$14.61
21 Jul 23BuyUS$4,998Ron BentsurIndividual335US$15.06
19 Jul 23BuyUS$118,720Charles Mosseri-MarlioIndividual8,000US$14.84
19 Jul 23BuyUS$2,866Ron BentsurIndividual200US$14.33
18 Jul 23BuyUS$135,771Charles Mosseri-MarlioIndividual9,149US$14.84
14 Jul 23BuyUS$4,035Ron BentsurIndividual260US$16.19
12 Jul 23BuyUS$49,571Charles Mosseri-MarlioIndividual3,285US$15.09
11 Jul 23BuyUS$153,600Charles Mosseri-MarlioIndividual10,000US$15.36
07 Jul 23BuyUS$135,920Charles Mosseri-MarlioIndividual8,948US$15.19
06 Jul 23BuyUS$47,717Charles Mosseri-MarlioIndividual3,179US$15.01
06 Jul 23BuyUS$4,762Ron BentsurIndividual320US$14.88
05 Jul 23BuyUS$18,252Charles Mosseri-MarlioIndividual1,176US$15.52
26 Jun 23BuyUS$275,870Charles Mosseri-MarlioIndividual16,760US$16.46
26 Jun 23BuyUS$12,375Ron BentsurIndividual750US$16.50
23 Jun 23BuyUS$1,275,440Charles Mosseri-MarlioIndividual73,175US$17.43
22 Jun 23BuyUS$231,964Charles Mosseri-MarlioIndividual13,090US$17.73
21 Jun 23BuyUS$8,940Ron BentsurIndividual500US$17.88
16 Jun 23BuyUS$225,425Charles Mosseri-MarlioIndividual12,700US$17.75
15 Jun 23BuyUS$568,848Charles Mosseri-MarlioIndividual32,124US$17.71
08 Jun 23BuyUS$6,108Ron BentsurIndividual350US$17.53
31 May 23BuyUS$5,702Ron BentsurIndividual330US$17.28
24 May 23BuyUS$3,498Ron BentsurIndividual200US$17.49
16 May 23BuyUS$5,448Ron BentsurIndividual320US$17.03

Insider Trading Volume

Insider Buying: NVCT insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NVCT?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,2780.00696%
Institutions2,473,97413.5%
General Public4,159,76922.6%
Individual Insiders11,735,73763.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.7%.

Top Shareholders

Top 25 shareholders own 76.51% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
16.5%
Ron Bentsur
3,022,484US$20.4m2.54%no data
14.1%
Charles Mosseri-Marlio
2,595,000US$17.5m0%no data
13%
Charles Marlio
2,380,176US$16.1m0%no data
7.34%
Enrique Poradosu
1,348,819US$9.1m-10.3%no data
7.17%
Shay Shemesh
1,316,955US$8.9m-11.7%no data
4.99%
Pontifax Venture Capital
917,400US$6.2m-33.5%1.9%
4.95%
Thomas Peters
908,475US$6.1m-4.13%no data
2.11%
BlackRock, Inc.
387,891US$2.6m7.91%no data
1.6%
The Vanguard Group, Inc.
294,283US$2.0m1.08%no data
0.84%
Baldwin Brothers, LLC
154,130US$1.0m8.51%0.08%
0.72%
Geode Capital Management, LLC
131,657US$890.0k1.54%no data
0.64%
State Street Global Advisors, Inc.
118,279US$799.6k9.39%no data
0.4%
Kenneth Hoberman
73,140US$494.4k0%no data
0.34%
Northern Trust Global Investments
61,574US$416.2k12.6%no data
0.29%
Matthew Kaplan
53,760US$363.4k0%no data
0.28%
Renaissance Technologies LLC
51,800US$350.2k104%no data
0.19%
Millennium Management LLC
34,011US$229.9k0%no data
0.19%
J.M. Forbes & Co. LLP
34,000US$229.8k0%0.02%
0.15%
James Oliviero
27,828US$188.1k0%no data
0.15%
GSA Capital Partners LLP
27,313US$184.6k0%0.01%
0.14%
Susquehanna International Group, LLP, Asset Management Arm
25,670US$173.5k0%no data
0.14%
Marshall Wace LLP
24,813US$167.7k-31.2%no data
0.12%
Morgan Stanley, Investment Banking and Brokerage Investments
22,843US$154.4k570%no data
0.12%
Two Sigma Investments, LP
22,771US$153.9k0%no data
0.11%
Charles Schwab Investment Management, Inc.
19,920US$134.7k0%no data
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.